1. Home
  2. VERA vs ERO Comparison

VERA vs ERO Comparison

Compare VERA & ERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

N/A

Current Price

$35.05

Market Cap

3.0B

Sector

Health Care

ML Signal

N/A

Logo Ero Copper Corp.

ERO

Ero Copper Corp.

N/A

Current Price

$35.47

Market Cap

2.8B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
VERA
ERO
Founded
2016
2016
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.8B
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
VERA
ERO
Price
$35.05
$35.47
Analyst Decision
Strong Buy
Buy
Analyst Count
10
2
Target Price
$81.30
$36.50
AVG Volume (30 Days)
1.8M
1.5M
Earning Date
05-06-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$51.94
Revenue Next Year
$472.48
$2.43
P/E Ratio
N/A
$22.61
Revenue Growth
N/A
N/A
52 Week Low
$22.72
$16.37
52 Week High
$56.05
$40.83

Technical Indicators

Market Signals
Indicator
VERA
ERO
Relative Strength Index (RSI) 46.52 49.98
Support Level $29.66 $24.04
Resistance Level $37.13 $36.25
Average True Range (ATR) 1.70 1.83
MACD 0.12 -0.50
Stochastic Oscillator 38.42 11.75

Price Performance

Historical Comparison
VERA
ERO

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About ERO Ero Copper Corp.

Ero Copper Corp is a high-margin, high-growth copper producer with operations in Brazil. Its primary asset is its 99.6% ownership interest in Mineracao Caraiba S.A., held indirectly through its wholly-owned subsidiary. The company also owns a 97.6% ownership interest in NX Gold S.A. indirectly through its wholly-owned subsidiary. Its reporting segments include its three operating mines in Brazil, the Caraiba Operations, the Tucuma Operation, and the Xavantina Operations, and its corporate head office in Canada.

Share on Social Networks: